Michael Lilly is an Oncology physician affiliated with Medical University of South Carolina. OpenAlex indexes 182 publications with 5,826 citations (h-index 44); ClinicalTrials.gov lists 11 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
39 Sabin Street
725 Walton Bldg
Charleston, SC 29425
Telephone
843-792-0592Provider last certified this registry record 2 Mar 2022.
Clinical trials
- Addition of Opaganib to Androgen Antagonists in Patients With mCRPC
Sponsor: Medical University of South Carolina
- Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients
Sponsor: Medical University of South Carolina
- Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
Sponsor: Medical University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- EMD Millipore CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
59%Androgen Receptor Inhibitor26%Xtandi73%Bicalutamide27%Part D≥25 patientsCytochrome P450 17A1 Inhibitor24.5%Abiraterone Acetate74%Zytiga26%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
21.7%Corticosteroid21.7%Prednisone100%Part D≥32 patientsNervous system
6.6%Opioid Agonist3.8%Oxycodone Hcl100%Part D≥11 patientsPhenothiazine2.8%Prochlorperazine Maleate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 2013–2021 per NIH RePORTER. The latest:
- CDK8/19 inhibitors for therapy of advanced prostate cancer
Senex Biotechnology, Inc.
FY2021$846,340R44CA203184 - CDK8/19 inhibitors for therapy of advanced prostate cancer
Senex Biotechnology, Inc.
FY2020$1,130,935R44CA203184 - Medical University of South Carolina Transdisciplinary Collaborative Center in Precision Medicine and Minority Men's Health
Medical University of South Carolina
FY2020$240,050U54MD010706
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
Andrew Atz, MD
Medical University of South Carolina
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”